Well-known sun care brand Coppertone has tackled a sun care need not often talked about — tattoos. For 2013, the brand launched its Tattoo Guard products to help protect against UVA and UVB rays that can fade or blur tattoos.
Sales of Hyland’s oral analgesic products are up 23.5% to $15.4 million for the 52 weeks ended Aug. 11 across U.S. multi-outlets, according to IRI. Overall sales trends across the category are down by 1.7%, which suggests that what Hyland’s is doing is right — its products are safe, they work and they aren’t formulated with benzocaine.
One subcategory that has really jolted the sales-per-square-inch across analgesic sets is sleep aids. Sales of sleeping remedies, including both liquids and tablets, were up 51.2% to $408 million for the 52 weeks ended Aug. 11 across U.S. multi-outlets, according to IRI data.
i-Health’s Estroven has been dialing up sales tracked within feminine pain relievers. The core brand generated $16.2 million within the last 52 weeks ended Aug. 11 across U.S. multi-outlets, according to IRI.
Such iconic pain relief brands as McNeil Consumer’s Tylenol and Motrin, and Novartis’ Excedrin, have made their way back to the shelf this fall following a recall-driven hiatus. And the sales have already started to accumulate.
Many of the larger probiotic brands are experiencing significant growth. i-Health’s Culturelle generated $61.6 million in sales on a growth rate of 44.5% for the 52 weeks ended Aug. 11, according to IRI data across U.S. multi-outlets. And sales of Bayer’s Phillips Colon Health were up 18.5% to $58.7 million.
Pharmavite launched its latest VMS innovation, Nature Made VitaMelts, earlier this summer, and already the brand ranks No. 12 among one- and two-letter vitamins, according to 52-week sales data as tracked by IRI.